Summary
The absorption of proscillaridin A was studied in four patients undergoing catheterization of the portal vein for diagnostic purposes. Proscillaridin 1.5 mg was given as a single oral dose and plasma glycoside activity was analyzed by the86Rb-uptake inhibition technique. Proscillaridin appeared rapidly in the portal blood, peak activity being found after 15 min in three and after 30 min in one patient. In peripheral blood the peak activity occurred after approximately 35 min. Despite rapid passage across the gut wall, porto-peripheral differences in glycoside activity were small; they were zero after 4 h. The mean amount absorbed as active proscillaridin during the first 4 h after the dose was calculated to be only 7.1% of the given amount. Late porto-peripheral differences, probably due to enterohepatic recycling, appeared after 6 h in three patients. The results suggest that proscillaridin undergoes first pass inactivation in the gut wall. Enterohepatic recirculation may contribute to the amounts of active glycoside that reach the systemic circulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersson, K.-E., Bertler, Å., Redfors, A.: In vitro stability of proscillaridin A. Europ. J. clin. Pharmacol.8, 135–139 (1975a)
Andersson, K.-E., Bertler, Å., Redfors, A.: On the pharmacokinetics of proscillaridin A in man. Europ. J. clin. Pharmacol.8, 421–425 (1975b)
Andersson, K.-E., Nyberg, L., Dencker, H., Göthlin, J.: Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization. Europ. J. clin. Pharmacol.9, 39–47 (1975c)
Andersson, K.-E., Bergdahl, B., Bertler, Å., Redfors, A.: On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects. Acta pharmacol. (Kbh.) In press (1976a)
Andersson, K.-E., Bergdahl, B., Wettrell, G.: Biliary excretion and enterohepatic recycling of proscillaridin after oral administration to man. Europ. J. clin. Pharmacol. In press (1976b)
Andersson, K.-E., Bergdahl, B., Dencker, H., Wettrell, G.: Activities of proscillaridin A in thoracic duct lymph after single oral doses in man. Acta pharmacol. (Kbh.) In press (1976c)
Bell, G. H., Davidson, J. N., Scarborough, H.: Textbook of Physiology and Biochemistry, 6th ed., p. 290. Edinburgh and London: Livingstone 1965
Belz, G. G.: Klinisch, experimentelle Untersuchungen mit dem Herzglykosid Proscillaridin unter besonderer Berücksichtigung seiner enteralen Resorptionsquote. Med. Klin.63, 96–102 (1968)
Belz, G. G., Brech, W. J.: Plasmaspiegel und Kumulationsverhalten von Proscillaridin bei Niereninsuffizienz. Klin. Wschr.52, 640–644 (1974)
Belz, G. G., Stauch, M., Rudofsky, G.: Plasma levels after a single dose of proscillaridin. Europ. J. clin. Pharmacol.7, 95–97 (1974a)
Belz, G. G., Nübling, H., Schmidt-Wiederkehr, P., Franz, H. E.: Plasmakonzentrationen und Elimination von Methylproscillaridin bei Niereninsuffizienz. Klin. Wschr.52, 1078–1081 (1974b)
Belz, G. G., Belz, G., Schreiter, H.: Glykosidplasmaspiegel und Electrokardiogramm nach einmaliger intravenöser und oraler Applikation von Methylproscillaridin bei gesunden Probanden. Verh. dtsch. Ges. inn. Med.80, 1080–1083 (1974c)
Belz, G. G., Nübling, H., Belz, G.: Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man. Arzneimittel-Forsch.26, 277–278 (1976)
Bertler, Å., Redfors, A.: An improved method of estimating digoxin in human plasma. Clin. Pharmacol. Ther.11, 665–673 (1970)
Boström, H., Brömster, D., Nordenstam, H., Wengle, B.: On the occurrence of phenol and steroid sulphokinases in the human gastrointestinal tract. Scand. J. Gastroent.3, 369–375 (1968)
Diczfalusy, E., Franksson, C., Lisboa, B. P., Martinsen, B.: Formation of oestrone glucosiduronate by the human intestinal tract. Acta endocr. (Kbh.)40, 537–551 (1962)
Forth, W., Furukawa, E., Rummel, W., Andres, H.: Intestinale Resorption von Herzglykosiden in vitro und in vivo. Naunyn-Schmiedeberg's Arch. Pharmak. exp. Path.262, 53–72 (1969)
Hartiala, K.: Metabolism of hormones, drugs and other substances by the gut. Physiol. Rev.53, 496–534 (1973)
Hänel, J., Meiffert, G.: Klinisch. experimentelle Studie zur Charakterisierung eines Herzglykosids. Med. Welt. (Berl.)19, 1404–1408 (1966)
Löschhorn, N.: Probleme der quantitativen Prüfung von Herzglykosiden, dargestellt an Proscillaridin. Therapiewoche19, 1529–1532 (1969)
Meier, G., Wagner, G.: Therapeutische Erfahrungen mit einem neuen Herzglykosid: Proscillaridin A. Med. Welt. (Berl.)18, 1995–2002 (1965)
Nübling, H., Belz, G. G., Bader, H.: The influence of digoxin metabolites on86Rb-uptake of human erythrocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl.287, R 41 (1975)
Rietbrock, N., Staud, R.: Metabolism and excretion of methylproscillaridin in man. Europ. J. clin. Pharmacol.8, 427–432 (1975)
Staud, R., Rietbrock, N., Fasbender, H. P.: Excretion of methylproscillaridin in patients with a biliary fistula. Europ. J. clin. Pharmacol.9, 99–103 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersson, K.E., Bergdahl, B., Dencker, H. et al. Proscillaridin activity in portal and peripheral venous blood after oral administration to man. Eur J Clin Pharmacol 11, 277–281 (1977). https://doi.org/10.1007/BF00607677
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607677